日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization

鉴定并表征了一种新型甲型流感病毒抑制剂,该抑制剂通过阻断核蛋白寡聚化发挥作用。

Leonard, Vincent H J; Vidales, Dianna B; Taft, Benjamin R; Hesse, Matthew J; Lee, Patrick S; Mamo, Mulugeta; Bussiere, Dirksen E; Wolff, Karen C; Kuhen, Kelli L; Wedel, Laura; Growcott, Ellena; Osborne, Colin; Octaviani, Cassio P; Huang, Pinghan; Tseng, Chien-Te Kent; Abend, Johanna R; Wong, Kelly A; Zhong, Weidong; Tully, David C; Ganem, Don

Superior replication, pathogenicity, and immune evasion of a Texas dairy cattle H5N1 virus compared to a historical avian isolate.

与历史上分离的禽流感病毒相比,德克萨斯州奶牛 H5N1 病毒具有更强的复制能力、致病性和免疫逃避能力

Octaviani Cassio Pontes, Huang Pinghan, Bi-Hung Peng, Gray Gregory C, Tseng Chien-Te K

Characterizing temporal and global host innate immune responses against SARS-CoV-1 and -2 infection in pathologically relevant human lung epithelial cells.

对病理相关的人类肺上皮细胞中针对 SARS-CoV-1 和 -2 感染的宿主先天免疫反应的时间性和整体性进行表征

Tat Vivian Y, Drelich Aleksandra K, Huang Pinghan, Khanipov Kamil, Hsu Jason C, Widen Steven G, Tseng Chien-Te Kent, Golovko George

An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.

口服生物利用度高的 SARS-CoV-2 主蛋白酶抑制剂表现出更高的亲和力和更低的突变敏感性

Westberg Michael, Su Yichi, Zou Xinzhi, Huang Pinghan, Rustagi Arjun, Garhyan Jaishree, Patel Puja Bhavesh, Fernandez Daniel, Wu Yan, Hao Chenzhou, Lo Chieh-Wen, Karim Marwah, Ning Lin, Beck Aimee, Saenkham-Huntsinger Panatda, Tat Vivian, Drelich Aleksandra, Peng Bi-Hung, Einav Shirit, Tseng Chien-Te K, Blish Catherine, Lin Michael Z

Evaluation of Type I Interferon Treatment in Hospitalized COVID-19 Patients: A Retrospective Cohort Study

评估I型干扰素治疗COVID-19住院患者的疗效:一项回顾性队列研究

Tat, Vivian Y; Huang, Pinghan; Khanipov, Kamil; Tat, Nathan Y; Tseng, Chien-Te Kent; Golovko, George

A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta

一种泛变异株mRNA-LNP T细胞疫苗可保护HLA转基因小鼠免于感染SARS-CoV-2 β病毒后的死亡。

Carter, Brandon; Huang, Pinghan; Liu, Ge; Liang, Yuejin; Lin, Paulo J C; Peng, Bi-Hung; McKay, Lindsay G A; Dimitrakakis, Alexander; Hsu, Jason; Tat, Vivian; Saenkham-Huntsinger, Panatda; Chen, Jinjin; Kaseke, Clarety; Gaiha, Gaurav D; Xu, Qiaobing; Griffiths, Anthony; Tam, Ying K; Tseng, Chien-Te K; Gifford, David K